Beneficial effect of flavone derivatives on aβ-induced memory deficit is mediated by peroxisome proliferator-activated receptor coactivator 1α: A comparative study

International Journal of Toxicology

Volumn 34, Issue 3, 2015, Pages 274-283

  Arsalandeh, Farshad ^a   Ahmadian, Shahin ^a   Foolad, Forough ^b   Khodagholi, Fariba ^b   Farimani, Mahdi M ^c   Shaerzadeh, Fatemeh ^b  

^a UNIVERSITY OF TEHRAN   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHAHID BEHESHTI UNIVERSITY   (Iran)

Author keywords

4 trihydroxyflavone; 5 hydroxy 6,7,4 trimethoxyflavone,5,7; Alzheimer's disease; amyloid beta (A ); flavonoid; mitochondrial biogenesis

Indexed keywords

5 HYDROXY 6,7,4' TRIMETHOXYFLAVONE; AMYLOID BETA PROTEIN; APIGENIN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; FLAVONE DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; MITOCHONDRIAL TRANSCRIPTION FACTOR A; NUCLEAR RESPIRATORY FACTOR 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; UNCLASSIFIED DRUG; 5,7,4'-TRIHYDROXYFLAVONE; CREB1 PROTEIN, RAT; MITOCHONDRIAL PROTEIN; NERVE PROTEIN; NEUROPROTECTIVE AGENT; NOOTROPIC AGENT; PPARGC1A PROTEIN, RAT; SALVIGENIN; TRANSCRIPTION FACTOR;

ADULT; AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN MITOCHONDRION; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG MECHANISM; HIPPOCAMPUS; MALE; MEMORY; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION SWELLING; NEUROPROTECTION; NONHUMAN; PASSIVE AVOIDANCE; PASSIVE AVOIDANCE TEST; RAT; WESTERN BLOTTING; AGONISTS; ALZHEIMER DISEASE; ANIMAL; ANIMAL BEHAVIOR; AVOIDANCE BEHAVIOR; DIETARY SUPPLEMENT; DISEASE MODEL; METABOLISM; MITOCHONDRIAL DYNAMICS; NERVE CELL; PHOSPHORYLATION; PROTEIN PROCESSING; WISTAR RAT;

RATTUS;

ALZHEIMER DISEASE; ANIMALS; AVOIDANCE LEARNING; BEHAVIOR, ANIMAL; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DIETARY SUPPLEMENTS; DISEASE MODELS, ANIMAL; FLAVONES; HIPPOCAMPUS; MALE; MEMORY; MITOCHONDRIAL DYNAMICS; MITOCHONDRIAL PROTEINS; NERVE TISSUE PROTEINS; NEURONS; NEUROPROTECTIVE AGENTS; NOOTROPIC AGENTS; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; RATS, WISTAR; TRANSCRIPTION FACTORS;

EID: 84930410941     PISSN: 10915818     EISSN: 1092874X     Source Type: Journal    
DOI: 10.1177/1091581815584165     Document Type: Article

References (73)

1. Iqbal K, Flory M, Khatoon S, et al. Subgroups of Alzheimer's disease based on cerebrospinal fluid molecular markers. Ann Neurol. 2005 ; 58 (5). 748-757
2. Evans DA, Funkenstein HH, Albert MS, et al. Prevalance of Alzheimer's Disease in a community population of older persons. JAMA. 1989 ; 262 (18). 2551-2556
3. Selkoe DJ. Amyloid beta-protein and the genetics of Alzheimer's disease. J Biol Chem. 1996 ; 271 (31). 18295-18298
4. Moreira PI, Carvalho C, Zhu X, Smith MA, Perry G. Mitochondrial dysfunction is a trigger of Alzheimer's disease pathophysiology. Biochem Biophys Acta. 2010 ; 1802 (1). 2-10
5. Bishop NA, Lu T, Yankner BA. Neural mechanisms of ageing and cognitive decline. Nature. 2010 ; 464 (7288). 529-535
6. Bender A, Krishnan KJ, Morris CM, et al. High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease. Nat Genet. 2006 ; 38 (5). 515-517
7. Gimenez-Roqueplo AP, Favier J, Rustin P, et al. The R22X mutation of the SDHD gene in hereditary paraganglioma abolishes the enzymatic activity of complex II in the mitochondrial respiratory chain and activates the hypoxia pathway. Am J Hum Genet. 2001 ; 69 (6). 1186-1197
8. Kraytsberg Y, Kudryavtseva E, McKee AC, Geula C, Kowall NW, Khrapko K. Mitochondrial DNA deletions are abundant and cause functional impairment in aged human substantia nigra neurons. Nat Genet. 2006 ; 38 (5). 518-520
9. Murphy MP. How mitochondria produce reactive oxygen species. Biochem J. 2009 ; 417 (1). 1-13
10. Pagliarini DJ, Calvo SE, Chang B, et al. A mitochondrial protein compendium elucidates complex I disease biology. Cell. 2008 ; 134 (1). 112-123
11. Mancuso M, Coppedè F, Murri L, Siciliano G. Mitochondrial cascade hypothesis of Alzheimer's disease: myth or reality?. Antioxid Redox Signal. 2007 ; 9 (10). 1631-1646
12. Reddy PH. Mitochondrial dysfunction in aging and Alzheimer's disease: strategies to protect neurons. Antioxid Redox Signal. 2007 ; 9 (10). 647-658
13. Barsoum MJ, Yuan H, Gerencser AA, et al. Nitric oxide induced mitochondrial fission is regulated by dynamin-related GTPases in neurons. EMBO J. 2006 ; 25 (16). 3900-3911
14. Benard G, Bellance N, James D, et al. Mitochondrial bioenergetics and structural network organization. J Cell Sci. 2007 ; 120 (pt 5). 838-848
15. Yoon YS, Yoon DS, Lim IK, et al. Formation of elongated giant mitochondria in DFO-induced cellular senescence: involvement of enhanced fusion process through modulation of Fis1. J Cell Physiol. 2006 ; 209 (2). 468-480
16. Fannin SW, Lesnefsky EJ, Slabe TJ, Hassan MO, Hoppel CL. Aging selectively decreases oxidative capacity in rat heart interfibrillar mitochondria. Arch Biochem Biophys. 1999 ; 372 (2). 399-407
17. Sugiyama S, Takasawa M, Hayakawa M, Ozawa T. Changes in skeletal muscle, heart and liver mitochondrial electron transport activities in rats and dogs of various ages. Biochem Mol Biol Int. 1993 ; 30 (5). 937-944
18. Spencer JP. The impact of fruit flavonoids on memory and cognition. Br J Nutr. 2010 ; 104 (suppl 3). S40 - S47
19. Pasinetti GM, Wang J, Porter S, Ho L. Caloric intake, dietary lifestyles, macronutrient composition, and Alzheimer' disease dementia. Int J Alzheimers Dis. 2011 ; 806293: 2011
20. Scalbert A, Williamson G. Dietary Intake and bioavailability of polyphenols. J Nutr. 2000 ; 130 (8S suppl). 2073S - 2085S
21. Williams RJ, Spencer JP, Rice-Evans C. Flavonoids: antioxidants or signalling molecules?. Free Radic Biol Med. 2004 ; 36 (7). 838-849
22. Spencer JP. Flavonoids and brain health: multiple effects underpinned by common mechanisms. Genes Nutr. 2009 ; 4 (4). 243-250
23. St-Pierre J, Drori S, Uldry M, et al. Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. Cell. 2006 ; 127 (2). 397-408
24. Wang J, Ferruzzi MG, Ho L, et al. Brain-targeted proanthocyanidin metabolites for Alzheimer's disease treatment. J Neurosci. 2012 ; 32 (15). 5144-5150
25. Lai HC, Wu MJ, Chen PY, et al. Neurotrophic effect of citrus 5-hydroxy- 3,6,7,8,30,40 hexamethoxyflavone: promotion of neurite outgrowth via cAMP/PKA/CREB pathway in PC12 cells. PLoS One. 2011 ; 6 (11). e28280
26. Kamatou GPP Indigenous Salvia Species: An Investigation of their Pharmacological Activities and Phytochemistry. South Africa: Faculty of Health Sciences, University of the Witwatersrand ; 2006 :
27. Singh JPV, Selvendiran K, Banu SM, Padmavathi R, Sakthisekaran D. Protective role of Apigenin on the status of lipid peroxidation and antioxidant defense against hepatocarcinogenesis in Wistar albino rats. Phytomedicine. 2004 ; 11 (4). 309-314
28. Bingol LM, Sener B. A review of terrestrial plants and marine organisms having anti-inflammatory activity. Int J Pharmacogn. 1995 ; 33 (2). 81-97
29. Ha SK, Lee P, Park JA, et al. Apigenin inhibits the production of NO and PGE2 in microglia and inhibits neuronal cell death in a middle cerebral artery occlusion-induced focal ischemia mice model. Neurochem Int. 2008 ; 52 (4-5). 878-886
30. Wang CN, Chi CW, Lin YL, Chen CF, Shiao YJ. The neuroprotective effects of phytoestrogens on amyloid β protein induced toxicity are mediated by abrogating the activation of caspase cascade in rat cortical neurons. J Biol Chem. 2001 ; 276 (7). 5287-5295
31. Zhao L, Wang J, Wang Y, Fa X. Apigenin attenuates copper-mediated β-amyloid neurotoxicity through antioxidation, mitochondrion protection and MAPK signalin activation in an AD cell model. Brain Res. 2013 ; 1492: 33-45
32. Chacón MA, Barría MI, Soto C, Inestrosa NC. Beta-sheet breaker peptide prevents Abeta-induced spatial memory impairments with partial reduction of amyloid deposits. Mol Psychiatry. 2004 ; 9 (10). 953-961
33. Borbély E, Horváth J, Furdan S, Bozsó Z, Penke B, Fülöp L. Simultaneous changes of spatial memory and spine density after intrahippocampal administration of fibrillar aβ1-42 to the rat brain. Biomed Res Int. 2014 ; 2014: 345305
34. Jantaratnotai N, Ryu JK, Schwab C, McGeer PL, McLarnon JG. Comparison of Vascular Perturbations in an Aβ-Injected Animal Model and in AD Brain. Int J Alzheimers Dis. 2011 ; 918280: 2011
35. Moghaddam FM, Farimani MM, Seirafi M, et al. Sesterterpenoids and other constituents of Salvia sahendica. J Nat Prod. 2010 ; 73 (9). 1601-1605
36. Farimani MM, Taheri S, Moghaddam FM, et al. Chemical Constituents from Salvia macrosiphon Boiss. Chem Nat Compd. 2008 ; 44: 518-519
37. Paxinos G, Watson CR The Rat Brain in Stereotaxic Coordinates. 6 th edn. New York: Academic press; 2007. New York: Academic press ; 2007 :
38. Bradford M. A rapid and sensitive method for the quantitation of micro-gram quantities of protein utilizing the principle of proteindye binding. Anal Biochem. 1976 ; 72: 248-254
39. Clarke JB, Nicklas WJ. The metabolism of rat brain mitochondria preparation and characterization. J Biol Chem. 1970 ; 245 (18). 4724-4731
40. Pipatpiboon N, Pratchayasakul W, Chattipakorn N, Chattipakorn SC. PPART agonist improves neuronal insulin receptor function in hippocampus and brain mitochondria function in rats with insulin resistance induced by long term high-fat diets. Endocrinology. 2012 ; 153 (1). 329-338
41. Kyoa RC, Fujita H, Shimizu S, et al. Gelsolin inhibits apoptosis by blocking mitochondrial membrane potential loss and cytochrome c release. J Biol Chem. 2000 ; 275 (20). 15343-15349
42. Veerendra Kumar MH, Gupta YK. Effect of Centella Asiatica on cognition and oxidative stress in an intracerebroventricular streptozotocin model of Alzheimer's disease in rat. Clin Exp Pharmacol Physiol. 2003 ; 30 (5-6). 336-342
43. Puigserver P, Wu Z, Park CW, Graves R, Wright M, Spiegelman BM. A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell. 1998 ; 92 (6). 829-839
44. Jordan J, Cena V, Prehn JH. Mitochondrial control of neuron death and its role in neurodegenerative disorders. J Physiol Biochem. 2003 ; 59 (2). 129-141
45. Pollard SE, Kuhnle GG, Vauzour D, et al. The reaction of flavonoid metabolites with peroxynitrite. Biochem Biophys Res Commun. 2006 ; 350 (4). 960-968
46. Williams RJ, Spencer JP. Flavonoids, cognition, and dementia: Actions, mechanisms, and potential therapeutic utility for Alzheimer disease. Free Rad Bio Med. 2012 ; 52 (1). 35-45
47. Scarpulla RC. Nuclear control of respiratory chain expression by nuclear respiratory factors and PGC-1-related coactivator. Ann N Y Acad Sci. 2008 ; 1147: 321-334
48. Scarpulla RC. Transcriptional activators and coactivators in the nuclear control of mitochondrial function in mammalian cells. Gene. 2002 ; 286 (1). 81-89
49. Kanki T, Ohgaki K, Gaspari M, et al. Architectural role of TFAM in maintenance of human mitochondrial DNA. Mol Cell Biol. 2004 ; 24 (22). 9823-9834
50. Kang D, Hamasaki N. Mitochondrial transcription factor A in the maintenance of mitochondrial DNA: overview of its multiple roles. Ann NY Acad Sci. 2005 ; 1042: 101-108
51. Scarpulla RC. Nuclear control of respiratory gene expression in mammalian cells. J Cell Biochem. 2006 ; 97 (4). 673-683
52. Hirai K, Aliev G, Nunomura A, et al. Mitochondrial abnormalities in Alzheimer's disease. J Neurosci. 2001 ; 21 (9). 3017-3023
53. Manczak M, Jung Y, Park BS, Partovi D, Reddy PH. Timecourse of mitochondrial gene expressions in mice brains: implications for mitochondrial dysfunction, oxidative damage, and cytochrome c in aging. J Neurochem. 2005 ; 92 (3). 494-504
54. Liang W, Reiman E, Valla J, et al. Alzheimer's disease is associated with reduced expression of energy metabolism genes in posterior cingulated neurons. Proc Natl Acad Sci U S A. 2008 ; 105 (11). 4441-4446
55. Monte S, Luong T, Neely T, Robinson D, Wands JR. Mitochondrial DNA damage as a mechanism of cell loss in Alzheimer's disease. Lab Invest. 2000 ; 80 (8). 1323-1335
56. Chandrasekaran K, Giordano T, Brady D, Stoll J, Martin LJ, Rapoport SI. Impairment in mitochondrial cytochrome oxidase gene expression in Alzheimer disease. Brain Res Mol Brain Res. 1994 ; 24 (1-4). 336-340
57. Jornayvaz FR, Shulman GI. Regulation of mitochondrial biogenesis. Essays Biochem. 2010 ; 47: 69-84
58. Shaerzadeh F, Motamedi F, Minai-Tehrani D, Khodagholi F. Monitoring of neuronal loss in the hippocampus of Aβ-injected rat: Autophagy, mitophagy and mitochondrial biogenesis stand against apoptosis. Neuromolecular Med. 2014 ; 16 (1). 175-190
59. Hayashi Y, Yoshida M, Yamato M, et al. Reverse of age-dependent memory impairment and mitochondrial DNA damage in microglia by an overexpression of human mitochondrial transcription factor a in mice. J Neurosci. 2008 ; 28 (34). 8624-8634
60. Reznick RM, Zong H, Li J, et al. Aging-associated reductions in AMP activated protein kinase activity and mitochondrial biogenesis. Cell Metab. 2007 ; 5 (2). 151-156
61. Lu J, Wu DM, Zheng YL, et al. Quercetin activates AMP-activated protein kinase by reducing PP2C expression protecting old mouse brain against high cholesterol-induced neurotoxicity. J Pathol. 2010 ; 222 (2). 199-212
62. Tschape JA, Hammerschmied C, Mühlig-Versen M, Athenstaedt K, Daum G, Kretzschmar D. The neurodegeneration mutant lochrig interferes with cholesterol homeostasis and Appl processing. EMBO J. 2002 ; 21 (23). 6367-6376
63. Won JS, Im YB, Kim J, Singh AK, Singh I. Involvement of AMP-activated-protein-kinase (AMPK) in neuronal amyloidogenesis. Biochem Biophys Res Commun. 2010 ; 399 (4). 487-491
64. Bachurin SO, Shevtsova EP, Kirevva EG, Oxwnkrug GF, Sablin SO. Mitochondria as a Target for Neurotoxins and Neuroprotective Agents. Ann NY Acad Sci. 2003 ; 993: 334-344
65. Fiskum G. Mitochondrial participation in ischemic and traumatic neural cell death. J Neurotrauma. 2000 ; 17 (10). 843-855
66. Gorman AM, Ceccatelli S, Orrenius S. Role of mitochondria in neuronal apoptosis. Dev Neurosci. 2000 ; 22 (5-6). 348-358
67. Blass JP. Brain metabolism and brain disease: is metabolic deficiency the proximate cause of Alzheimer dementia?. J Neurosci Res. 2001 ; 66 (5). 851-856
68. Moreira PI, Santos MS, Moreno A, Oliveira C. Amyloid beta-peptide promotes permeability transition pore in brain mitochondria. Biosci Rep. 2001 ; 21 (6). 789-800
69. Moreira PI, Santos MS, Moreno A, Rego AC, Oliveira C. Effect of amyloid beta peptide on permeability transition pore: a comparative study. J Neurosci Res. 2002 ; 69 (2). 257-267
70. Mungarro-Menchaca X, Frrera P, Moran J, Arias C. beta-Amyloid peptide induces ultrastructural changes in synaptosomes and potentiates mitochondrial dysfunction in the presence of ryanodine. J Neurosci Res. 2002 ; 68 (1). 89-96
71. Sirk D, Zhu Z, Wadia JS, et al. Chronic exposure to sub-lethal beta-amyloid inhibits the import of nuclear encoded proteins to mitochondria in differentiated PC12 cells. J Neurochem. 2007 ; 103 (5). 1989-2003
72. Fiorani M, Guidarelli A, Blasa M, et al. Mitochondria accumulate large amounts of quercetin: prevention of mitochondrial damage and release upon oxidation of the extra-mitochondrial fraction of the flavonoid. J Nutr Biochem. 2010 ; 21 (5). 397-404
73. Youdim KA, Dobbie MS, Kuhnle G, Proteggente AR, Abbott NJ, Rice-Evans C. Interaction between flavonoids and the blood-brain barrier: in vitro studies. J Neurochem. 2003 ; 85 (1). 180-192